| Aleah Gonzalez, | |
|
293 Van Nostrand Ave, Jersey City, NJ 07305-2130 | |
| (917) 474-0104 | |
| Not Available |
| Full Name | Aleah Gonzalez |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Home Health |
| Location | 293 Van Nostrand Ave, Jersey City, New Jersey |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255119095 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WH0200X | Registered Nurse - Home Health | 760168 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Aleah Gonzalez, 293 Van Nostrand Ave, Jersey City, NJ 07305-2130 Ph: () - | Aleah Gonzalez, 293 Van Nostrand Ave, Jersey City, NJ 07305-2130 Ph: (917) 474-0104 |
News Archive
Scientists at the Hebrew University of Jerusalem have reported a major breakthrough in understanding the molecular basis for Prader-Willi syndrome (PWS), perhaps the most studied among the class of diseases that involves defects in parental imprinting.
Researchers from the Spanish National Cancer Research Centre have discovered more than 40 genes that predict the level of aggressiveness of melanoma and that distinguish it from other cancers with a poor prognosis. The discovery, published in Cancer Cell, will help to identify unique aspects of melanoma that could contribute to determine the risk of developing metastasis in patients with this disease.
A newly published study recommends that doctors carefully choose their patients' initial therapies because there are significant differences in overall survival rates, according to researchers at the University of Rochester Medical Center's James P. Wilmot Cancer Center.
Obesity can break down our protective blood brain barrier resulting in problems with learning and memory, scientists report.
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that an oral presentation at the Annual Meeting of the American Society of Clinical Oncology (ASCO) will feature Phase 2 trial data with tivantinib as a single agent investigational second-line treatment in hepatocellular carcinoma (HCC).
› Verified 5 days ago
Ms. Marigold Brillantes-benguan, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 74 Mcadoo Ave, Jersey City, NJ 07305 Phone: 646-331-5611 | |
Pulcherie Kamga Kenye Fossie, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 3688 Kennedy Blvd, Apt-3, Jersey City, NJ 07307 Phone: 718-671-2100 | |
Kristen Mccabe, Registered Nurse Medicare: Medicare Enrolled Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2200 | |
Mr. Daniel Harmeyer, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 355 Grand St, Jersey City, NJ 07302 Phone: 201-915-2000 | |
Anastacia Nyamongo, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 416 Cator Ave # 2, Jersey City, NJ 07305 Phone: 201-705-2324 | |
Jamie Beth Owens, RN, IBCLC Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 116 Mercer St, 1a, Jersey City, NJ 07302 Phone: 203-417-5961 | |
Mrs. Molly Virginia Walker, RN, CNM, MSN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: Horizon Health Center, 714 Bergen Avenue, Jersey City, NJ 07306 Phone: 201-451-6300 Fax: 201-451-0619 |